Literature DB >> 22566606

Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10.

Kevin Oakley1, Yufen Han, Bandana A Vishwakarma, Su Chu, Ravi Bhatia, Kristbjorn O Gudmundsson, Jonathan Keller, Xiongfong Chen, Vasyl Vasko, Nancy A Jenkins, Neal G Copeland, Yang Du.   

Abstract

Acquisition of self-renewal capability by myeloid progenitors to become leukemic stem cells during myeloid leukemia development is poorly understood. Here, we show that Setbp1 overexpression efficiently confers self-renewal capability to myeloid progenitors in vitro, causing their immortalization in the presence of stem cell factor and IL-3. Self-renewal after immortalization requires continuous Setbp1 expression. We also found that Hoxa9 and Hoxa10 mRNA are present at dramatically higher levels in Setbp1-immortalized cells compared with other immortalized cells, and are induced shortly after Setbp1 expression in primary myeloid progenitors. Suppression of either gene in Setbp1-immortalized cells drastically reduces their colony-forming capability. Interestingly, Setbp1 protein associates with Hoxa9 and Hoxa10 promoters in chromatin immunoprecipitation assays in these cells, suggesting that both are direct transcriptional targets of Setbp1. Setbp1 also promotes self-renewal of myeloid progenitors in vivo as its coexpression with BCR/ABL transforms primary mouse myeloid progenitors, generating aggressive leukemias in recipient mice resembling chronic myelogenous leukemia (CML) myeloid blast crisis. Increased SETBP1 mRNA levels were also detected in a subset of CML advanced phase/blast crisis patients with high levels of HOXA9 and HOXA10 expression. Thus, Setbp1 activation represents a novel mechanism conferring self-renewal capability to myeloid progenitors in myeloid leukemia development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566606      PMCID: PMC3383018          DOI: 10.1182/blood-2011-10-388710

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.

Authors:  K Akashi; D Traver; T Miyamoto; I L Weissman
Journal:  Nature       Date:  2000-03-09       Impact factor: 49.962

2.  Two functionally distinct forms of the RSC nucleosome-remodeling complex, containing essential AT hook, BAH, and bromodomains.

Authors:  B R Cairns; A Schlichter; H Erdjument-Bromage; P Tempst; R D Kornberg; F Winston
Journal:  Mol Cell       Date:  1999-11       Impact factor: 17.970

3.  Dual functions of largest NURF subunit NURF301 in nucleosome sliding and transcription factor interactions.

Authors:  H Xiao; R Sandaltzopoulos; H M Wang; A Hamiche; R Ranallo; K M Lee; D Fu; C Wu
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

4.  Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.

Authors:  S B Seo; P McNamara; S Heo; A Turner; W S Lane; D Chakravarti
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

5.  Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET.

Authors:  M Minakuchi; N Kakazu; M J Gorrin-Rivas; T Abe; T D Copeland; K Ueda; Y Adachi
Journal:  Eur J Biochem       Date:  2001-03

6.  The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

Authors:  Yingzi Wang; Andrei V Krivtsov; Amit U Sinha; Trista E North; Wolfram Goessling; Zhaohui Feng; Leonard I Zon; Scott A Armstrong
Journal:  Science       Date:  2010-03-26       Impact factor: 47.728

7.  Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.

Authors:  U Thorsteinsdottir; E Kroon; L Jerome; F Blasi; G Sauvageau
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

8.  Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.

Authors:  K R Calvo; D B Sykes; M Pasillas; M P Kamps
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

9.  Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia.

Authors:  Fumio Nakahara; Mamiko Sakata-Yanagimoto; Yukiko Komeno; Naoko Kato; Tomoyuki Uchida; Kyoko Haraguchi; Keiki Kumano; Yuka Harada; Hironori Harada; Jiro Kitaura; Seishi Ogawa; Mineo Kurokawa; Toshio Kitamura; Shigeru Chiba
Journal:  Blood       Date:  2009-10-27       Impact factor: 22.113

10.  Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice.

Authors:  George S Vassiliou; Jonathan L Cooper; Roland Rad; Juan Li; Stephen Rice; Anthony Uren; Lena Rad; Peter Ellis; Rob Andrews; Ruby Banerjee; Carolyn Grove; Wei Wang; Pentao Liu; Penny Wright; Mark Arends; Allan Bradley
Journal:  Nat Genet       Date:  2011-03-27       Impact factor: 38.330

View more
  42 in total

1.  Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.

Authors:  Ivo P Touw; Renée Beekman
Journal:  Haematologica       Date:  2013-10       Impact factor: 9.941

2.  BRCC3 mutations in myeloid neoplasms.

Authors:  Dayong Huang; Yasunobu Nagata; Vera Grossmann; Tomas Radivoyevitch; Yusuke Okuno; Genta Nagae; Naoko Hosono; Susanne Schnittger; Masashi Sanada; Bartlomiej Przychodzen; Ayana Kon; Chantana Polprasert; Wenyi Shen; Michael J Clemente; James G Phillips; Tamara Alpermann; Kenichi Yoshida; Niroshan Nadarajah; Mikkael A Sekeres; Kevin Oakley; Nhu Nguyen; Yuichi Shiraishi; Yusuke Shiozawa; Kenichi Chiba; Hiroko Tanaka; H Phillip Koeffler; Hans-Ulrich Klein; Martin Dugas; Hiroyuki Aburatani; Satoru Miyano; Claudia Haferlach; Wolfgang Kern; Torsten Haferlach; Yang Du; Seishi Ogawa; Hideki Makishima
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

3.  Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia.

Authors:  Jasmijn D E de Rooij; Eva Beuling; Marry M van den Heuvel-Eibrink; Askar Obulkasim; André Baruchel; Jan Trka; Dirk Reinhardt; Edwin Sonneveld; Brenda E S Gibson; Rob Pieters; Martin Zimmermann; C Michel Zwaan; Maarten Fornerod
Journal:  Haematologica       Date:  2015-06-11       Impact factor: 9.941

Review 4.  Somatic SETBP1 mutations in myeloid neoplasms.

Authors:  Hideki Makishima
Journal:  Int J Hematol       Date:  2017-04-26       Impact factor: 2.490

5.  Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.

Authors:  Nils Winkelmann; Vivien Schäfer; Jenny Rinke; Alexander Kaiser; Philipp Ernst; Sebastian Scholl; Andreas Hochhaus; Thomas Ernst
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-14       Impact factor: 4.553

Review 6.  Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.

Authors:  Danilo Perrotti; Giovannino Silvestri; Lorenzo Stramucci; Justine Yu; Rossana Trotta
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

7.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

8.  Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.

Authors:  Linlin Shao; Zheng Chen; Wael El-Rifai; Dunfa Peng; Mohammed Soutto; Shoumin Zhu; Andreia Bates; Shutian Zhang
Journal:  Mol Cancer Res       Date:  2018-02-16       Impact factor: 5.852

Review 9.  Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.

Authors:  Katerina Zoi; Nicholas C P Cross
Journal:  Int J Hematol       Date:  2014-09-12       Impact factor: 2.490

10.  An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Nicholas C P Cross; Eric Padron; Ramon V Tiu; Michael Savona; Luca Malcovati; Raoul Tibes; Rami S Komrokji; Jean-Jacques Kiladjian; Guillermo Garcia-Manero; Attilio Orazi; Ruben Mesa; Jaroslaw P Maciejewski; Pierre Fenaux; Raphael Itzykson; Ghulam Mufti; Eric Solary; Alan F List
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.